Univariable and multivariable analysis
Variable . | Univariable . | Multivariable . | ||||
---|---|---|---|---|---|---|
RR . | 95% CI . | P . | RR . | 95% CI . | P . | |
Factors predicting TTP using the conventional Mayo risk stratification system | ||||||
Bone marrow plasma cells (≥10%) | 0.3 | 0.1-5.1 | .31 | NA | ||
Serum M-spike (≥3 g/dL) | 2.0 | 1.3-2.9 | .002 | 2.2 | 1.3-3.5 | .003 |
sFLC ratio (≥8) | 2.2 | 1.5-3.4 | .0001 | 2.3 | 1.5-3.6 | .0002 |
Elevated PCPI | 2.0 | 1.3-3.0 | .001 | 2.5 | 1.6-3.9 | <.0001 |
Immunoparesis | 1.6 | 1.0-2.5 | .04 | 1.2 | 0.8-2.1 | .39 |
Factors predicting TTP using the proposed new Mayo risk stratification system | ||||||
Bone marrow plasma cells (>20%) | 2.7 | 1.8-4.1 | <.0001 | 2.2 | 1.4-3.5 | <0.0008 |
Serum M-spike (>2 g/dL) | 2.2 | 1.5-3.2 | <.0001 | 1.9 | 1.2-3.0 | 0.007 |
sFLC ratio (>20) | 2.7 | 1.8-4.1 | <.0001 | 2.7 | 1.7-4.2 | 0.22 |
Elevated PCPI | 2.0 | 1.3-3.0 | .001 | 2.3 | 1.4-3.5 | 0.0007 |
Immunoparesis | 1.6 | 1.0-2.5 | .04 | 1.0 | 0.6-1.7 | 0.97 |
Variable . | Univariable . | Multivariable . | ||||
---|---|---|---|---|---|---|
RR . | 95% CI . | P . | RR . | 95% CI . | P . | |
Factors predicting TTP using the conventional Mayo risk stratification system | ||||||
Bone marrow plasma cells (≥10%) | 0.3 | 0.1-5.1 | .31 | NA | ||
Serum M-spike (≥3 g/dL) | 2.0 | 1.3-2.9 | .002 | 2.2 | 1.3-3.5 | .003 |
sFLC ratio (≥8) | 2.2 | 1.5-3.4 | .0001 | 2.3 | 1.5-3.6 | .0002 |
Elevated PCPI | 2.0 | 1.3-3.0 | .001 | 2.5 | 1.6-3.9 | <.0001 |
Immunoparesis | 1.6 | 1.0-2.5 | .04 | 1.2 | 0.8-2.1 | .39 |
Factors predicting TTP using the proposed new Mayo risk stratification system | ||||||
Bone marrow plasma cells (>20%) | 2.7 | 1.8-4.1 | <.0001 | 2.2 | 1.4-3.5 | <0.0008 |
Serum M-spike (>2 g/dL) | 2.2 | 1.5-3.2 | <.0001 | 1.9 | 1.2-3.0 | 0.007 |
sFLC ratio (>20) | 2.7 | 1.8-4.1 | <.0001 | 2.7 | 1.7-4.2 | 0.22 |
Elevated PCPI | 2.0 | 1.3-3.0 | .001 | 2.3 | 1.4-3.5 | 0.0007 |
Immunoparesis | 1.6 | 1.0-2.5 | .04 | 1.0 | 0.6-1.7 | 0.97 |
RR, relative risk; CI, confidence interval.